Cargando…
High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
BACKGROUND: Copy number polymorphisms caused by genomic rearrangements like deletions, make a significant contribution to the genomic differences between two individuals and may add to disease predisposition. Therefore, genotyping of such deletion polymorphisms in case-control studies could give imp...
Autores principales: | Wagner, Kerstin, Grzybowska, Ewa, Butkiewicz, Dorota, Pamula-Pilat, Jolanta, Pekala, Wioletta, Tecza, Karolina, Hemminki, Kari, Försti, Asta |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925117/ https://www.ncbi.nlm.nih.gov/pubmed/17598925 http://dx.doi.org/10.1186/1471-2156-8-41 |
Ejemplares similares
-
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018) -
Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015) -
Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015) -
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2016) -
Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
por: Pamuła-Piłat, Jolanta, et al.
Publicado: (2020)